Medi-Pot Most Often Consumed For Pain, Muscle Spasms, Study Says
“These data suggest that the patient population has evolved from mostly HIV/AIDS and cancer patients to a...
more infoCannabinoid Treatments: Multiple sclerosis (MS)
Investigators at the University of California at San Diego reported in 2008 that inhaled cannabis significantly reduced objective measures of pain intensity and spasticity in patients with MS in a placebo-controlled, randomized clinical trial. Investigators concluded that “smoked cannabis was superior to placebo in reducing spasticity and pain in patients with multiple sclerosis and provided some benefit beyond currently prescribed treatment.”
more infoNY TIMES: Marijuana for Patients Remains Off-Limits
New Jersey — Irvina Booker makes a most unlikely criminal. She lives in constant pain, disabled by multiple...
more infoBBC NEWS: Cannabis effects on MS trialled
Patients are being recruited for a trial to determine whether chemicals in cannabis can slow the impact of...
more infoMultiple sclerosis changes man’s outlook on marijuana
Today, at age 54, Timmons is mostly bedridden and rarely sees the outside of his Garland home. What he lacks in...
more infoVideo: Benefits of Juicing Raw Marijuana
Dr. Courtney is a physician and researcher from Mendocino, California, who gives medical marijuana approvals to...
more infoNational Multiple Sclerosis Society: Marijuana
Some people with MS report that smoking marijuana relieves several of their MS symptoms. However, for any therapy...
more infoMarijuana Chemical May Slow Multiple Sclerosis
In lieu of curing a debilitating disease, the next best thing scientists can do is slow its progression and...
more infoSmoking Pot Doesn’t Harm Brain Function – UCSD Study
Los Angeles — Smoking marijuana will certainly affect perception, but it does not cause permanent brain...
more infoIf the Feds Get Their Way, Big Pharma Could Sell Pot – But Your Dime Bag Would Still Send You to Jail
We should be very wary about the DEA allowing regulation and marketing of pharmaceutical products containing...
more infoSmoked cannabis for chronic neuropathic pain: a randomized controlled trial
BACKGROUND Chronic neuropathic pain affects 1%-2% of the adult population and is often refractory to standard...
more infoCannabinoid System in Neuroprotection, Raphael Mechoulam PhD
Raphael Mechoulam PhD presents explanation of cannabinoid receptors. Why would our cells have receptors specifically intended to receive cannabinoids if we were not meant to be assimilated into the body?
This is an excellent video and focuses on the scientific data to support Raphael Mechoulam PhD assertions.
more info
